Results of the STAR*D study: implications for clinicians and drug developers.
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, Kansas, USA.
D000928:Antidepressive Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000188:drug therapy*; D004345:Drug Industry; D004361:Drug Tolerance; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors